health pharma news today obesity drugs glp-1 today What is the pipeline for future medications for obesity? Drugmaker Eli Lilly announced that

GLP1 receptor agonists (GLP-1s) are prescription drugs widely used to manage type 2 diabetes, obesity and related chronic conditions such as cardiovascular disease and fatty liver disease

Shopping multiple pharmacies, optimizing doses, and checking online programs further cuts out-of-pocket costs for weight loss medications while ensuring safety

Dietary supplements are not appropriate for everyone and may interact with other supplements or medications, so talk to your health care provider before adding one to your routine

Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, et al

Shi, S., Kanasaki, K

Several theories exist: The additive effects theory suggests that GIP and GLP-1 work through partially independent pathways